Table 2. Multivariable models with eGFR as a continuous and dichotomous outcome (hyperfiltration).

	eGFR Cystatin C		eGFR > 120 mL/min/1.73 m2 by Cystatin C
	β±SE**	p-value	OR, 95% CI***	p-value
Non-stratified models
Glucose *	0.14±0.04	<0.0001	1.04 (1.01-1.07)	0.02
No RAASi (No ACEi/ARB use)
Glucose *	0.14±0.05	0.005	1.04 (1.00-1.09)	0.03
RAASi (ACEi/ARB use)
Glucose *	0.13±0.07	0.07	1.02 (0.96–1.09)	0.43

*Multivariable models adjusted for gender, HbA1c, protein and sodium intake and ACEi/ARB use. **β-coefficient represents the difference in eGFR for every 10-unit increase for glucose (e.g., 10 mg/dL for blood glucose) in the independent variable, and difference for every 1-unit difference for the other variables.

***Odds ratios represent the average odds of hyperfiltration for every 10-unit increase in glucose, and for every 1-unit difference for the other variables.